Medicinal products for the Oncology Clinic 2026/2027
Status
Active
Submission Deadline
28 days remaining
Contracting authority
Location
гр. София, Bulgaria
Estimated Value
€148,241
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-606802-2026
Source
Pharmaceutical products for the Oncology Clinic, according to Appendix 2 of the NHIF list for the years 2026 and 2027: various oncological medications in different dosages and forms, including Avapritinib, Atezolizumab, Brigatinib, Dostarlimab, Everolimus, Fruquintinib, Mirvetuximab Soravtansine, Ripretinib, Rucaparib, Sacituzumab Govitecan, Sotorasib, Talazoparib, Tepotinib, Tremelimumab, Vemurafenib, and Zolbetuximab. Specific quantities are detailed in the individual lots.
Free
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 606802-2026HTML
- TED PDF — 606802-2026PDF
- TED XML — 606802-2026XML
Free
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Lots (28)
- LOT-0001Avapritinib 25 mg Filmtabletten€148,241
- LOT-0002Avapritinib 50 mg Filmtabletten€296,503
- LOT-0003Avapritinib 100 mg Filmtabletten€1,482,489
- LOT-0004Atezolizumab 1875 mg Injektionslösung€989,529
- LOT-0005Brigatinib 30 mg Filmtabletten€50,159
- LOT-0006Brigatinib 90 mg Filmtabletten€150,476
- LOT-0007Brigatinib 180 mg Filmtabletten€300,951
- LOT-0008Brigatinib 90 mg + 180 mg Filmtabletten€263,339
- LOT-0009Dostarlimab 500 mg Konzentrat zur Infusionslösung€1,654,470
- LOT-0010Everolimus 5 mg Tabletten€10,406
- LOT-0011Everolimus 10 mg Tabletten€20,812
- LOT-0012Fruquintinib 1 mg Hartkapseln€288,338
- LOT-0013Fruquintinib 5 mg Hartkapseln€1,441,783
- LOT-0014Mirvetuximab Soravtansine 5 mg/ml Konzentrat zur Infusionslösung€309,857
- LOT-0015Mirvetuximab Soravtansine 240 mg/80 mg Konzentrat zur Infusionslösung€328,530
- LOT-0016Ripretinib 50 mg Tabletten€1,650,942
- LOT-0017Ripretinib 200 mg Filmtabletten€343,332
- LOT-0018Rucaparib 250 mg Filmtabletten€343,332
- LOT-0019Rucaparib 300 mg Filmtabletten€343,332
- LOT-0020Sacituzumab Govitecan 200 mg Pulver zur Herstellung einer Infusionslösung€639,058
- LOT-0021Sotorasib 120 mg Filmtabletten€208,008
- LOT-0022Talazoparib 1 mg Hartkapseln€167,184
- LOT-0023Talazoparib 0,25 mg Hartkapseln€417,960
- LOT-0024Tepotinib 225 mg Filmtabletten€270,173
- LOT-0025Tremelimumab 300 mg/15 ml Konzentrat zur Infusionslösung€1,296,551
- LOT-0026Vemurafenib 240 mg Filmtabletten€191,923
- LOT-0027Zolbetuximab 100 mg Pulver zur Herstellung eines Konzentrats zur Infusionslösung€47,293
- LOT-0028Zolbetuximab 300 mg Pulver zur Herstellung eines Konzentrats zur Infusionslösung€141,881
Additional details
EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024